Initiatives from El Salvador, Mexico, and the United States of America recognized with World No Tobacco Day Awards

2Firsts Events
Jun.13.2022

Washington D.C. May 27 2022 (PAHO) – A tobacco control advocate in El Salvador, Violeta de Palomo, the President of Mexico, Andres Manuel Lopez Obrador, and a researcher and academic from the United States of America, Thomas Novotny, received the 2022 World No Tobacco Day (WNTD) Awards.

The winners, selected by the World Health Organization (WHO) from global nominations in response to a public call, have been recognized for their efforts to ensure progress towards tobacco control in their countries.

Initiatives from El Salvador, Mexico, and the United States of America recognized with World No Tobacco Day Awards

In El Salvador, Violeta de Palomo won the award for her work with Fundahabla, an organization she founded in 2014 to provide health care, psychological support, speech therapy, and rehabilitation for people with laryngeal cancer. As a leader of the anti-tobacco movement in El Salvador, Violeta also coordinates the @sumatecontraeltabaco initiative to ensure 100% smoke-free public spaces, support for smoking cessation, and advocacy for increasing taxes on tobacco products.

 

In Mexico, President Andres Manuel Lopez Obrador received the WHO Director-General’s Special Recognition Award for his leadership and unwavering support for strengthening tobacco control measures in his country. His efforts led to the unanimous approval of the reform of the General Law for Tobacco Control in 2021, which has resulted in a complete ban on tobacco advertising, promotion and sponsorship, as well as the creation of smoke-free environments throughout the country. Over the course of the past year, Lopez Obrador has reaffirmed the importance of tobacco control, ensuring that the right to health of all Mexicans supersedes the interests of the tobacco industry.

 

In the United States, Thomas Novotny, Professor Emeritus at San Diego State University School of Public Health, won the award in recognition of his research and advocacy around the environmental impact of tobacco, particularly regarding post-consumer waste such as filters. Novotny is a founding member of the Cigarette Butt Pollution Project (CBPP), an organization that campaigns against the environmental impact of tobacco products, particularly cigarette butts.

World No Tobacco Day was created by WHO Member States in 1987 and is commemorated each year on 31 May. The aim of the day is to raise awareness of the harmful effects of tobacco use and second-hand smoke exposure.

 

The theme of World Not Tobacco Day 2022 is “Poisoning our planet”. Tobacco kills over 8 million people every year and destroys the environment, further harming human health through its cultivation, production, distribution, consumption, and through post-consumer waste.

 

Also read:

Juul Gets Temporary Reprieve to Keep Selling Its E-Cigarettes

Will the new Juul ban help Colorado’s high teen vape use?

Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
Wall Street Journal: U.S. FDA Plans Faster Vape and Nicotine Pouch Reviews, Revisit of 2021 PMTA Rule
The Trump administration is preparing changes intended to accelerate FDA market authorization reviews for e-cigarettes and nicotine pouches, according to The Wall Street Journal. The FDA is expected to revisit its 2021 PMTA rule and may simplify some scientific study requirements and shorten review times. The agency has not formally announced the changes. Over the past year, the FDA has already accelerated nicotine-pouch reviews, expanded ENDS authorizations and upgraded its CTP Portal NextGen application system. As of August 2026, 43 nicotine pouch products and 48 e-cigarette products had received FDA marketing authorization.
Sep.24
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
FRE and ALP Push Modern Oral to 48% of Q2 Sales as Turning Point Brands Changes CEO and Lowers Profit-Guidance Ceiling
Turning Point Brands said Executive Chairman David E. Glazek will become CEO on October 1, replacing Graham Purdy, who is stepping down for personal reasons. The company narrowed its 2026 adjusted EBITDA outlook to $70 million-$80 million from $70 million-$90 million while maintaining Modern Oral gross sales guidance of $330 million-$350 million and net sales guidance of $260 million-$270 million. In the second quarter, Modern Oral net sales rose 128% to $68.4 million and accounted for 48% of company-wide net sales. Adjusted EBITDA fell 50% year over year. TPB shares closed about 10% lower on September 21.
Market
Sep.22 by 2Firsts Perspectives
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
US ITC Judge Finds Glas Infringed Two JUUL Vape Patents, Recommends Restrictions on Related Imports——Glas Received FDA Marketing Authorization for Four Vape Pods in May 2026; Proposed Restrictions Remain Under Commission Review
A U.S. International Trade Commission (USITC) administrative law judge issued an initial determination on October 20, 2026, finding that certain Glas vaping devices, cartridges and components infringed 12 claims across two patents asserted by JUUL, constituting a violation of Section 337 of the Tariff Act of 1930. The judge recommended a limited exclusion order and a cease and desist order against the Glas respondents. Five months earlier, the FDA authorized four Glas e-cigarette pods, including mango, blueberry and two menthol variants. The patent investigation concerns device and cartridge structures and is separate from FDA premarket review. The proposed import restrictions have not become final, and their product-level scope remains unresolved.
company
Nov.05
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
PMI Pushes Smoke-Free Business in Latin America as Argentina Lifts Heated Tobacco Ban, Mexico City Share Tops 7%
Philip Morris International (PMI) showcased IQOS heated tobacco systems and nicotine pouch products at Technovation 2026 in Buenos Aires on October 7–8, presenting research on consumer attitudes, regulatory developments and illicit cigarette trade across Latin America. PMI Chief Global Growth Officer Stefano Volpetti said smoke-free products accounted for more than 7% of the Mexico City market. Argentina repealed its heated tobacco ban in May 2026 and introduced registration requirements for tobacco and nicotine products, while local media reported nicotine pouch sales in Mendoza. A PMI-commissioned survey found that only 8% of respondents across four Latin American countries were familiar with nicotine pouches. A separate KPMG study estimated illicit cigarette consumption at 77 billion sticks across 11 markets in Latin America and Canada in 2025.
PMI
Oct.13
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
On-Site Report | CTP Details PMTA Backlog, 180-Day Review Goal and sPMTA Process
FDA’s Center for Tobacco Products detailed new PMTA review data and process changes at the 2026 FDLI conference. Pending PMTAs fell from about 450,000 at the start of 2025 to 135,000 by September 2026. CTP also discussed its 180-day review goal, current sPMTA pilot, alternate-supplier planning, more than 50,300 pending SE reports, and lessons from the nicotine pouch pilot already being applied to ENDS review.
Regulations
Oct.07